Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

October 20, 2022

Study Completion Date

October 20, 2022

Conditions
BK Virus NephropathyBK Virus Infection
Interventions
BIOLOGICAL

Posoleucel (formerly known as ALVR105) cells

Infusion

BIOLOGICAL

Placebo (visually identical to Posoleucel)

Infusion

Trial Locations (33)

10016

NYU Langone Medical Center, New York

10021

Weil Medical College - NY Presbyterian Hospital, New York

11030

North Shore University Hospital, Manhasset

14215

Erie County Medical Center, Buffalo

15213

UPMC Montefiore Hospital, Pittsburgh

17101

UPMC Pinnacle-Harrisburg Hospital, Harrisburg

21201

University of Maryland Medical Center, Baltimore

21287

John Hopkins Hospital, Baltimore

22042

Inova Fairfax Medical Center, Falls Church

22908

University of Virginia, Charlottesville

23298

Virginia Commonwealth University, Richmond

27708

Duke University, Durham

29425

Medical University of South Carolina, Charleston

30309

Piedmont Hospital, Atlanta

44195

Cleveland Clinic Foundation, Cleveland

45229

University of Cincinnati Hospital, Cincinnati

46202

Indiana University Hospital, Indianapolis

48109

University of Michigan Medical Center, Ann Arbor

55455

University of Minnesota, Minneapolis

60153

Loyola University Medical Center, Maywood

60611

Northwestern University Transplant Center, Chicago

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Hospital, Kansas City

68198

University of Nebraska Medical Center, Omaha

70112

Tulane University School of Medicine, New Orleans

75204

Baylor University Medical Center, Dallas

75390

UT Southwestern Medical Center, Dallas

90033

Keck Medical Center of USC, Los Angeles

94143

University of California, San Francisco Medical Center, San Francisco

94306

Stanford University, Palo Alto

95817

University of California Davis Medical Center, Sacramento

02115

Harvard Medical School - Brigham & Women's Hospital, Boston

02905

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AlloVir

INDUSTRY

NCT04605484 - Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia | Biotech Hunter | Biotech Hunter